Thursday, August 16, 2018
Tags Opdivo

Tag: Opdivo

Study Preserves Hopes for Roche’s Tecentriq in Lung Cancer

By John Miller ZURICH (Reuters)  Swiss drugmaker Roche's hopes of having the first immunotherapy cocktail to be approved as an initial treatment for an aggressive form...

Mixed Results for Bristol/Nektar Combination in Cancer Trial

Chicago (Reuters) Mixed results over the weekend from closely watched studies combining Bristol-Myers Squibb Co's cancer immunotherapy with Nektar Therapeutics experimental drug NKTR-214, led...

Roche Drugs Show Limited Benefit in Lung, Breast Cancer Trials

By Deena Beasley CHICAGO (Reuters)  In a disappointment for Roche Holding AG, two of its oncology drugs provided only modest protection from disease progression in lung...

Roche, Chasing Merck, Notches Another Lung Cancer Win

By John Miller ZURICH (Reuters) Roche's bid to keep Merck's cancer blockbuster Keytruda within striking distance got a lift on Tuesday when the Swiss drugmaker...

Merck’s Keytruda Helps Lung Cancer Patients Live Longer in Trial

By Tamara Mathias (Reuters) Merck & Co's blockbuster drug Keytruda helped previously untreated lung cancer patients live longer in a late-stage trial, potentially cementing its...

Roche’s Tecentriq Notches Third Cancer Cocktail Trial Win

By John Miller ZURICH (Reuters) Roche's immunotherapy Tecentriq on Tuesday racked up a third trial win in combination with other cancer drugs, a boost for...
banner